Jonathan Knowles

Jonathan Kenneth Charles Knowles is the founder of The Innovative Medicines Initiative.
Current jobs include Director at Immunophotonics, Inc. since 2020, Director at Affibody Medical AB, Director at Targovax Oy since 2011, Director at MediSapiens Oy, Professor at École Polytechnique Fédérale de Lausanne, Professor at the University of Helsinki, and Member of the European Molecular Biology Organization.
Former jobs include Executive Chairman & Chief Executive Officer at Immunocore Holdings Plc from 2014 to 2015, Chairman at Hever Group, Vice Chairman at Caris Ltd. from 2009 to 2010, Chairman-Research Directors Group at the European Federation of Pharmaceutical Industries & Associations, Vice Chairman at Hermo Pharma Oy from 2013 to 2014, Chairman at Adaptimmune Therapeutics Plc from 2015 to 2016, Vice Chairman at Caris Life Sciences, Inc. from 2013 to 2026, Director at Genentech, Inc. from 1998 to 2009, Research Director at Glaxo Wellcome Plc from 1995 to 1997, Director at Chugai Pharmaceutical Co., Ltd., Non-Executive Director at Faron Pharmaceuticals Oy, Director at Agency for Science, Technology & Research from 2013 to 2017, Director at Lundbeck Ltd., Non-Executive Director at Adaptimmune Ltd. from 2010 to 2013, Director at Herantis Pharma Oyj, President-Group Research at F.
Hoffmann-La Roche Ltd., Trustee at Cancer Research UK, Head-Group Research at Roche Diagnostics Oy, Professor-Personalized Healthcare at Institute for Molecular Medicine Finland, and President-Group Research at Roche Holding AG from 1998 to 2010.
Education includes a doctorate from The University of Edinburgh conferred in 1973 and an undergraduate degree from the University of East Anglia conferred in 1969.